Skip to main content
. 2017 Feb 23;15(2):e04694. doi: 10.2903/j.efsa.2017.4694

Figure 31.

Figure 31

Trends in ampicillin, cefotaxime, ciprofloxacin nalidixic acid and tetracycline resistance in tested Salmonella spp. isolates from pigs in reporting MSs, 2009–2015, quantitative data

  • A statistically significant trend for 5 or more years, as tested by a logistic regression model (p ≤ 0.05), was observed in the Italy (↓) for both ciprofloxacin and nalidixic acid, for ampicillin in the Netherlands(↑), for ciprofloxacin in Estonia(↑), for cefotaxime in Italy (↑), and for tetracycline in Italy (↓) and the Netherlands (↑).